Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mifepristone 2.5 mg vs 5 mg for Uterine Fibroids
NCT01786226Phase 3Terminated
- Sponsor
- Mediterranea Medica
- Start
- Mar 2010
- Primary completion
- Mar 2012
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of mifepristone in Uterine Fibroids (UF), sponsored by Mediterranea Medica. Started Mar 2010; status: terminated.
02
Drugs
mifepristone
03
Conditions
Uterine Fibroids (UF)
Beyond the preview
Go deeper on NCT01786226.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01786226.